Sunday - June 2, 2024

RNA Interference Mediated Inhibition of Prolyl Hydroxylase Domain 2 (PHD2) Gene Expression Using Short Interfering Nucleic Acid (siNA)

2024-04-09

ALEXANDRIA, Virginia, April 9 -- SIRNA THERAPEUTICS, INC., Cambridge, Massachusetts has been assigned a patent (No. US 11952573 B2, initially filed April 1, 2022) developed by three inventors Brandon Ason, Pacifica, California; Duncan Brown, Berkeley, California; and Walter R. Strapps, Doylestown, Pennsylvania, for "RNA interference mediated inhibition of prolyl hydroxylase domain 2 (PHD2) gene expression using short interfering nucleic acid (siNA)." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

RNA Interference Mediated Inhibition of Prolyl Hydroxylase Domain 2 (PHD2) Gene Expression Using Short Interfering Nucleic Acid (siNA)

Information Request Form

Copyright Targeted News Service 2024